nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—ACE—forelimb zeugopod—skin cancer	0.0507	0.197	CbGeAlD
Ramipril—ACE—forelimb—skin cancer	0.0255	0.0992	CbGeAlD
Ramipril—ACE—hindlimb—skin cancer	0.023	0.0893	CbGeAlD
Ramipril—ACE—arm—skin cancer	0.0219	0.0852	CbGeAlD
Ramipril—ACE—appendage—skin cancer	0.0197	0.0766	CbGeAlD
Ramipril—ACE—nerve—skin cancer	0.014	0.0543	CbGeAlD
Ramipril—ACE—endothelium—skin cancer	0.0119	0.0462	CbGeAlD
Ramipril—ACE—blood vessel—skin cancer	0.011	0.0426	CbGeAlD
Ramipril—ACE—neck—skin cancer	0.00784	0.0305	CbGeAlD
Ramipril—SLC15A1—epithelium—skin cancer	0.00744	0.0289	CbGeAlD
Ramipril—SLC15A1—mammalian vulva—skin cancer	0.00646	0.0251	CbGeAlD
Ramipril—BCHE—nipple—skin cancer	0.00585	0.0228	CbGeAlD
Ramipril—ACE—connective tissue—skin cancer	0.00562	0.0219	CbGeAlD
Ramipril—ACE—epithelium—skin cancer	0.00533	0.0207	CbGeAlD
Ramipril—ACE—mammalian vulva—skin cancer	0.00463	0.018	CbGeAlD
Ramipril—ACE—lymphoid tissue—skin cancer	0.00411	0.016	CbGeAlD
Ramipril—ACE—female reproductive system—skin cancer	0.00396	0.0154	CbGeAlD
Ramipril—BCHE—skin of body—skin cancer	0.00375	0.0146	CbGeAlD
Ramipril—SLC15A2—female reproductive system—skin cancer	0.00346	0.0134	CbGeAlD
Ramipril—BCHE—mammalian vulva—skin cancer	0.00342	0.0133	CbGeAlD
Ramipril—ACE—head—skin cancer	0.00331	0.0129	CbGeAlD
Ramipril—BCHE—female reproductive system—skin cancer	0.00293	0.0114	CbGeAlD
Ramipril—SLC15A2—head—skin cancer	0.00289	0.0112	CbGeAlD
Ramipril—BCHE—head—skin cancer	0.00245	0.00951	CbGeAlD
Ramipril—ACE—lymph node—skin cancer	0.00232	0.00902	CbGeAlD
Ramipril—SLC15A2—lymph node—skin cancer	0.00202	0.00786	CbGeAlD
Ramipril—BCHE—lymph node—skin cancer	0.00171	0.00666	CbGeAlD
Ramipril—Visual impairment—Temozolomide—skin cancer	0.00115	0.00154	CcSEcCtD
Ramipril—Sinusitis—Fluorouracil—skin cancer	0.00115	0.00154	CcSEcCtD
Ramipril—Erythema—Dactinomycin—skin cancer	0.00115	0.00154	CcSEcCtD
Ramipril—Agranulocytosis—Fluorouracil—skin cancer	0.00114	0.00153	CcSEcCtD
Ramipril—Ill-defined disorder—Bleomycin—skin cancer	0.00114	0.00153	CcSEcCtD
Ramipril—Diarrhoea—Vemurafenib—skin cancer	0.00113	0.00152	CcSEcCtD
Ramipril—Erythema multiforme—Temozolomide—skin cancer	0.00113	0.00151	CcSEcCtD
Ramipril—Urticaria—Imiquimod—skin cancer	0.00112	0.00151	CcSEcCtD
Ramipril—Body temperature increased—Imiquimod—skin cancer	0.00112	0.0015	CcSEcCtD
Ramipril—Abdominal pain—Imiquimod—skin cancer	0.00112	0.0015	CcSEcCtD
Ramipril—Tinnitus—Temozolomide—skin cancer	0.00111	0.00149	CcSEcCtD
Ramipril—Malaise—Bleomycin—skin cancer	0.00111	0.00149	CcSEcCtD
Ramipril—Flushing—Temozolomide—skin cancer	0.0011	0.00149	CcSEcCtD
Ramipril—Leukopenia—Bleomycin—skin cancer	0.0011	0.00148	CcSEcCtD
Ramipril—Dizziness—Vemurafenib—skin cancer	0.00109	0.00147	CcSEcCtD
Ramipril—Immune system disorder—Temozolomide—skin cancer	0.00108	0.00145	CcSEcCtD
Ramipril—Mediastinal disorder—Temozolomide—skin cancer	0.00107	0.00144	CcSEcCtD
Ramipril—Cough—Bleomycin—skin cancer	0.00107	0.00144	CcSEcCtD
Ramipril—Ill-defined disorder—Dactinomycin—skin cancer	0.00106	0.00143	CcSEcCtD
Ramipril—Liver function test abnormal—Docetaxel—skin cancer	0.00106	0.00142	CcSEcCtD
Ramipril—Vomiting—Vemurafenib—skin cancer	0.00105	0.00142	CcSEcCtD
Ramipril—Alopecia—Temozolomide—skin cancer	0.00105	0.00142	CcSEcCtD
Ramipril—Chest pain—Bleomycin—skin cancer	0.00105	0.00141	CcSEcCtD
Ramipril—Myalgia—Bleomycin—skin cancer	0.00105	0.00141	CcSEcCtD
Ramipril—Abdominal pain upper—Docetaxel—skin cancer	0.00104	0.00141	CcSEcCtD
Ramipril—Orthostatic hypotension—Docetaxel—skin cancer	0.00104	0.00141	CcSEcCtD
Ramipril—Rash—Vemurafenib—skin cancer	0.00104	0.0014	CcSEcCtD
Ramipril—Mental disorder—Temozolomide—skin cancer	0.00104	0.0014	CcSEcCtD
Ramipril—Dermatitis—Vemurafenib—skin cancer	0.00104	0.0014	CcSEcCtD
Ramipril—Hypersensitivity—Imiquimod—skin cancer	0.00104	0.0014	CcSEcCtD
Ramipril—Headache—Vemurafenib—skin cancer	0.00104	0.0014	CcSEcCtD
Ramipril—Malnutrition—Temozolomide—skin cancer	0.00104	0.00139	CcSEcCtD
Ramipril—Erythema—Temozolomide—skin cancer	0.00104	0.00139	CcSEcCtD
Ramipril—Breast disorder—Docetaxel—skin cancer	0.00103	0.00139	CcSEcCtD
Ramipril—Discomfort—Bleomycin—skin cancer	0.00103	0.00139	CcSEcCtD
Ramipril—Malaise—Dactinomycin—skin cancer	0.00103	0.00139	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00103	0.00139	CcSEcCtD
Ramipril—Cramp muscle—Docetaxel—skin cancer	0.00103	0.00139	CcSEcCtD
Ramipril—Leukopenia—Dactinomycin—skin cancer	0.00103	0.00138	CcSEcCtD
Ramipril—Dysgeusia—Temozolomide—skin cancer	0.00101	0.00137	CcSEcCtD
Ramipril—Asthenia—Imiquimod—skin cancer	0.00101	0.00136	CcSEcCtD
Ramipril—Confusional state—Bleomycin—skin cancer	0.00101	0.00136	CcSEcCtD
Ramipril—Oedema—Bleomycin—skin cancer	0.001	0.00135	CcSEcCtD
Ramipril—Anaphylactic shock—Bleomycin—skin cancer	0.001	0.00135	CcSEcCtD
Ramipril—Pruritus—Imiquimod—skin cancer	0.000998	0.00134	CcSEcCtD
Ramipril—Dysphagia—Docetaxel—skin cancer	0.000989	0.00133	CcSEcCtD
Ramipril—Nausea—Vemurafenib—skin cancer	0.000983	0.00132	CcSEcCtD
Ramipril—Thrombocytopenia—Bleomycin—skin cancer	0.000981	0.00132	CcSEcCtD
Ramipril—Arrhythmia—Fluorouracil—skin cancer	0.00098	0.00132	CcSEcCtD
Ramipril—Myalgia—Dactinomycin—skin cancer	0.000975	0.00131	CcSEcCtD
Ramipril—Bronchospasm—Docetaxel—skin cancer	0.000973	0.00131	CcSEcCtD
Ramipril—Tremor—Temozolomide—skin cancer	0.000971	0.00131	CcSEcCtD
Ramipril—Alopecia—Fluorouracil—skin cancer	0.000969	0.0013	CcSEcCtD
Ramipril—Diarrhoea—Imiquimod—skin cancer	0.000965	0.0013	CcSEcCtD
Ramipril—Discomfort—Dactinomycin—skin cancer	0.000964	0.0013	CcSEcCtD
Ramipril—Angina pectoris—Docetaxel—skin cancer	0.000963	0.0013	CcSEcCtD
Ramipril—Ill-defined disorder—Temozolomide—skin cancer	0.000961	0.00129	CcSEcCtD
Ramipril—Anorexia—Bleomycin—skin cancer	0.000956	0.00129	CcSEcCtD
Ramipril—Erythema—Fluorouracil—skin cancer	0.000955	0.00129	CcSEcCtD
Ramipril—Agitation—Temozolomide—skin cancer	0.000952	0.00128	CcSEcCtD
Ramipril—Angioedema—Temozolomide—skin cancer	0.000947	0.00127	CcSEcCtD
Ramipril—Pancytopenia—Docetaxel—skin cancer	0.000939	0.00126	CcSEcCtD
Ramipril—Hypotension—Bleomycin—skin cancer	0.000937	0.00126	CcSEcCtD
Ramipril—Oedema—Dactinomycin—skin cancer	0.000935	0.00126	CcSEcCtD
Ramipril—Malaise—Temozolomide—skin cancer	0.000934	0.00126	CcSEcCtD
Ramipril—Dizziness—Imiquimod—skin cancer	0.000933	0.00126	CcSEcCtD
Ramipril—Vertigo—Temozolomide—skin cancer	0.000931	0.00125	CcSEcCtD
Ramipril—Leukopenia—Temozolomide—skin cancer	0.000927	0.00125	CcSEcCtD
Ramipril—Neutropenia—Docetaxel—skin cancer	0.000925	0.00124	CcSEcCtD
Ramipril—Palpitations—Temozolomide—skin cancer	0.000916	0.00123	CcSEcCtD
Ramipril—Thrombocytopenia—Dactinomycin—skin cancer	0.000915	0.00123	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000913	0.00123	CcSEcCtD
Ramipril—Cough—Temozolomide—skin cancer	0.000904	0.00122	CcSEcCtD
Ramipril—Paraesthesia—Bleomycin—skin cancer	0.0009	0.00121	CcSEcCtD
Ramipril—Weight increased—Docetaxel—skin cancer	0.0009	0.00121	CcSEcCtD
Ramipril—Convulsion—Temozolomide—skin cancer	0.000898	0.00121	CcSEcCtD
Ramipril—Vomiting—Imiquimod—skin cancer	0.000897	0.00121	CcSEcCtD
Ramipril—Dyspnoea—Bleomycin—skin cancer	0.000894	0.0012	CcSEcCtD
Ramipril—Anorexia—Dactinomycin—skin cancer	0.000891	0.0012	CcSEcCtD
Ramipril—Rash—Imiquimod—skin cancer	0.00089	0.0012	CcSEcCtD
Ramipril—Dermatitis—Imiquimod—skin cancer	0.000889	0.0012	CcSEcCtD
Ramipril—Headache—Imiquimod—skin cancer	0.000884	0.00119	CcSEcCtD
Ramipril—Myalgia—Temozolomide—skin cancer	0.000882	0.00119	CcSEcCtD
Ramipril—Arthralgia—Temozolomide—skin cancer	0.000882	0.00119	CcSEcCtD
Ramipril—Anxiety—Temozolomide—skin cancer	0.000879	0.00118	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000876	0.00118	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000874	0.00118	CcSEcCtD
Ramipril—Discomfort—Temozolomide—skin cancer	0.000872	0.00117	CcSEcCtD
Ramipril—Decreased appetite—Bleomycin—skin cancer	0.000871	0.00117	CcSEcCtD
Ramipril—Acute coronary syndrome—Docetaxel—skin cancer	0.000869	0.00117	CcSEcCtD
Ramipril—Renal failure—Docetaxel—skin cancer	0.000867	0.00117	CcSEcCtD
Ramipril—Myocardial infarction—Docetaxel—skin cancer	0.000864	0.00116	CcSEcCtD
Ramipril—Neuropathy peripheral—Docetaxel—skin cancer	0.000864	0.00116	CcSEcCtD
Ramipril—Dry mouth—Temozolomide—skin cancer	0.000863	0.00116	CcSEcCtD
Ramipril—Jaundice—Docetaxel—skin cancer	0.000859	0.00116	CcSEcCtD
Ramipril—Stomatitis—Docetaxel—skin cancer	0.000859	0.00116	CcSEcCtD
Ramipril—Conjunctivitis—Docetaxel—skin cancer	0.000857	0.00115	CcSEcCtD
Ramipril—Leukopenia—Fluorouracil—skin cancer	0.000855	0.00115	CcSEcCtD
Ramipril—Confusional state—Temozolomide—skin cancer	0.000853	0.00115	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000852	0.00115	CcSEcCtD
Ramipril—Anaphylactic shock—Temozolomide—skin cancer	0.000846	0.00114	CcSEcCtD
Ramipril—Oedema—Temozolomide—skin cancer	0.000846	0.00114	CcSEcCtD
Ramipril—Nausea—Imiquimod—skin cancer	0.000838	0.00113	CcSEcCtD
Ramipril—Hepatobiliary disease—Docetaxel—skin cancer	0.000834	0.00112	CcSEcCtD
Ramipril—Epistaxis—Docetaxel—skin cancer	0.000832	0.00112	CcSEcCtD
Ramipril—Nervous system disorder—Temozolomide—skin cancer	0.000829	0.00112	CcSEcCtD
Ramipril—Thrombocytopenia—Temozolomide—skin cancer	0.000828	0.00111	CcSEcCtD
Ramipril—Convulsion—Fluorouracil—skin cancer	0.000827	0.00111	CcSEcCtD
Ramipril—Feeling abnormal—Bleomycin—skin cancer	0.000826	0.00111	CcSEcCtD
Ramipril—Agranulocytosis—Docetaxel—skin cancer	0.000823	0.00111	CcSEcCtD
Ramipril—Skin disorder—Temozolomide—skin cancer	0.000821	0.00111	CcSEcCtD
Ramipril—Hyperhidrosis—Temozolomide—skin cancer	0.000817	0.0011	CcSEcCtD
Ramipril—Myalgia—Fluorouracil—skin cancer	0.000813	0.00109	CcSEcCtD
Ramipril—Chest pain—Fluorouracil—skin cancer	0.000813	0.00109	CcSEcCtD
Ramipril—Decreased appetite—Dactinomycin—skin cancer	0.000813	0.00109	CcSEcCtD
Ramipril—Fatigue—Dactinomycin—skin cancer	0.000806	0.00108	CcSEcCtD
Ramipril—Anorexia—Temozolomide—skin cancer	0.000806	0.00108	CcSEcCtD
Ramipril—Discomfort—Fluorouracil—skin cancer	0.000803	0.00108	CcSEcCtD
Ramipril—Urticaria—Bleomycin—skin cancer	0.000796	0.00107	CcSEcCtD
Ramipril—Body temperature increased—Bleomycin—skin cancer	0.000792	0.00107	CcSEcCtD
Ramipril—Hepatitis—Docetaxel—skin cancer	0.000791	0.00107	CcSEcCtD
Ramipril—Confusional state—Fluorouracil—skin cancer	0.000786	0.00106	CcSEcCtD
Ramipril—Oedema peripheral—Docetaxel—skin cancer	0.00078	0.00105	CcSEcCtD
Ramipril—Anaphylactic shock—Fluorouracil—skin cancer	0.000779	0.00105	CcSEcCtD
Ramipril—Oedema—Fluorouracil—skin cancer	0.000779	0.00105	CcSEcCtD
Ramipril—Connective tissue disorder—Docetaxel—skin cancer	0.000778	0.00105	CcSEcCtD
Ramipril—Feeling abnormal—Dactinomycin—skin cancer	0.00077	0.00104	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00077	0.00104	CcSEcCtD
Ramipril—Insomnia—Temozolomide—skin cancer	0.000765	0.00103	CcSEcCtD
Ramipril—Gastrointestinal pain—Dactinomycin—skin cancer	0.000764	0.00103	CcSEcCtD
Ramipril—Nervous system disorder—Fluorouracil—skin cancer	0.000764	0.00103	CcSEcCtD
Ramipril—Thrombocytopenia—Fluorouracil—skin cancer	0.000763	0.00103	CcSEcCtD
Ramipril—Visual impairment—Docetaxel—skin cancer	0.000763	0.00103	CcSEcCtD
Ramipril—Tachycardia—Fluorouracil—skin cancer	0.00076	0.00102	CcSEcCtD
Ramipril—Paraesthesia—Temozolomide—skin cancer	0.000759	0.00102	CcSEcCtD
Ramipril—Dyspnoea—Temozolomide—skin cancer	0.000754	0.00101	CcSEcCtD
Ramipril—Somnolence—Temozolomide—skin cancer	0.000752	0.00101	CcSEcCtD
Ramipril—Erythema multiforme—Docetaxel—skin cancer	0.000748	0.00101	CcSEcCtD
Ramipril—Dyspepsia—Temozolomide—skin cancer	0.000744	0.001	CcSEcCtD
Ramipril—Anorexia—Fluorouracil—skin cancer	0.000743	0.001	CcSEcCtD
Ramipril—Abdominal pain—Dactinomycin—skin cancer	0.000739	0.000995	CcSEcCtD
Ramipril—Body temperature increased—Dactinomycin—skin cancer	0.000739	0.000995	CcSEcCtD
Ramipril—Hypersensitivity—Bleomycin—skin cancer	0.000739	0.000994	CcSEcCtD
Ramipril—Decreased appetite—Temozolomide—skin cancer	0.000735	0.000989	CcSEcCtD
Ramipril—Flushing—Docetaxel—skin cancer	0.000735	0.000989	CcSEcCtD
Ramipril—Gastrointestinal disorder—Temozolomide—skin cancer	0.00073	0.000983	CcSEcCtD
Ramipril—Fatigue—Temozolomide—skin cancer	0.000729	0.000981	CcSEcCtD
Ramipril—Hypotension—Fluorouracil—skin cancer	0.000728	0.00098	CcSEcCtD
Ramipril—Constipation—Temozolomide—skin cancer	0.000723	0.000973	CcSEcCtD
Ramipril—Asthenia—Bleomycin—skin cancer	0.000719	0.000968	CcSEcCtD
Ramipril—Immune system disorder—Docetaxel—skin cancer	0.000715	0.000962	CcSEcCtD
Ramipril—Mediastinal disorder—Docetaxel—skin cancer	0.000713	0.00096	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00071	0.000955	CcSEcCtD
Ramipril—Pruritus—Bleomycin—skin cancer	0.000709	0.000955	CcSEcCtD
Ramipril—Arrhythmia—Docetaxel—skin cancer	0.000707	0.000952	CcSEcCtD
Ramipril—Insomnia—Fluorouracil—skin cancer	0.000705	0.000949	CcSEcCtD
Ramipril—Paraesthesia—Fluorouracil—skin cancer	0.0007	0.000942	CcSEcCtD
Ramipril—Alopecia—Docetaxel—skin cancer	0.000699	0.000941	CcSEcCtD
Ramipril—Feeling abnormal—Temozolomide—skin cancer	0.000697	0.000938	CcSEcCtD
Ramipril—Dyspnoea—Fluorouracil—skin cancer	0.000695	0.000935	CcSEcCtD
Ramipril—Mental disorder—Docetaxel—skin cancer	0.000693	0.000933	CcSEcCtD
Ramipril—Somnolence—Fluorouracil—skin cancer	0.000693	0.000932	CcSEcCtD
Ramipril—Gastrointestinal pain—Temozolomide—skin cancer	0.000691	0.000931	CcSEcCtD
Ramipril—Malnutrition—Docetaxel—skin cancer	0.000689	0.000927	CcSEcCtD
Ramipril—Erythema—Docetaxel—skin cancer	0.000689	0.000927	CcSEcCtD
Ramipril—Hypersensitivity—Dactinomycin—skin cancer	0.000689	0.000927	CcSEcCtD
Ramipril—Dyspepsia—Fluorouracil—skin cancer	0.000686	0.000923	CcSEcCtD
Ramipril—Decreased appetite—Fluorouracil—skin cancer	0.000677	0.000912	CcSEcCtD
Ramipril—Dysgeusia—Docetaxel—skin cancer	0.000675	0.000908	CcSEcCtD
Ramipril—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000673	0.000905	CcSEcCtD
Ramipril—Urticaria—Temozolomide—skin cancer	0.000672	0.000904	CcSEcCtD
Ramipril—Asthenia—Dactinomycin—skin cancer	0.000671	0.000903	CcSEcCtD
Ramipril—Body temperature increased—Temozolomide—skin cancer	0.000668	0.0009	CcSEcCtD
Ramipril—Abdominal pain—Temozolomide—skin cancer	0.000668	0.0009	CcSEcCtD
Ramipril—Muscle spasms—Docetaxel—skin cancer	0.000662	0.000892	CcSEcCtD
Ramipril—Feeling abnormal—Fluorouracil—skin cancer	0.000642	0.000864	CcSEcCtD
Ramipril—Diarrhoea—Dactinomycin—skin cancer	0.00064	0.000861	CcSEcCtD
Ramipril—Vomiting—Bleomycin—skin cancer	0.000637	0.000858	CcSEcCtD
Ramipril—Rash—Bleomycin—skin cancer	0.000632	0.000851	CcSEcCtD
Ramipril—Dermatitis—Bleomycin—skin cancer	0.000631	0.00085	CcSEcCtD
Ramipril—Hypersensitivity—Temozolomide—skin cancer	0.000623	0.000839	CcSEcCtD
Ramipril—Urticaria—Fluorouracil—skin cancer	0.000619	0.000833	CcSEcCtD
Ramipril—Syncope—Docetaxel—skin cancer	0.000618	0.000832	CcSEcCtD
Ramipril—Leukopenia—Docetaxel—skin cancer	0.000617	0.00083	CcSEcCtD
Ramipril—Body temperature increased—Fluorouracil—skin cancer	0.000616	0.000829	CcSEcCtD
Ramipril—Palpitations—Docetaxel—skin cancer	0.000609	0.00082	CcSEcCtD
Ramipril—Asthenia—Temozolomide—skin cancer	0.000607	0.000817	CcSEcCtD
Ramipril—Loss of consciousness—Docetaxel—skin cancer	0.000606	0.000815	CcSEcCtD
Ramipril—Cough—Docetaxel—skin cancer	0.000601	0.000809	CcSEcCtD
Ramipril—Pruritus—Temozolomide—skin cancer	0.000598	0.000805	CcSEcCtD
Ramipril—Convulsion—Docetaxel—skin cancer	0.000597	0.000804	CcSEcCtD
Ramipril—Nausea—Bleomycin—skin cancer	0.000595	0.000802	CcSEcCtD
Ramipril—Vomiting—Dactinomycin—skin cancer	0.000594	0.0008	CcSEcCtD
Ramipril—Rash—Dactinomycin—skin cancer	0.000589	0.000793	CcSEcCtD
Ramipril—Arthralgia—Docetaxel—skin cancer	0.000587	0.00079	CcSEcCtD
Ramipril—Myalgia—Docetaxel—skin cancer	0.000587	0.00079	CcSEcCtD
Ramipril—Chest pain—Docetaxel—skin cancer	0.000587	0.00079	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000583	0.000784	CcSEcCtD
Ramipril—Diarrhoea—Temozolomide—skin cancer	0.000579	0.000779	CcSEcCtD
Ramipril—Hypersensitivity—Fluorouracil—skin cancer	0.000574	0.000773	CcSEcCtD
Ramipril—Dry mouth—Docetaxel—skin cancer	0.000574	0.000772	CcSEcCtD
Ramipril—Confusional state—Docetaxel—skin cancer	0.000567	0.000763	CcSEcCtD
Ramipril—Oedema—Docetaxel—skin cancer	0.000562	0.000757	CcSEcCtD
Ramipril—Anaphylactic shock—Docetaxel—skin cancer	0.000562	0.000757	CcSEcCtD
Ramipril—Dizziness—Temozolomide—skin cancer	0.000559	0.000753	CcSEcCtD
Ramipril—Nausea—Dactinomycin—skin cancer	0.000555	0.000748	CcSEcCtD
Ramipril—Shock—Docetaxel—skin cancer	0.000553	0.000745	CcSEcCtD
Ramipril—Nervous system disorder—Docetaxel—skin cancer	0.000551	0.000742	CcSEcCtD
Ramipril—Pruritus—Fluorouracil—skin cancer	0.000551	0.000742	CcSEcCtD
Ramipril—Thrombocytopenia—Docetaxel—skin cancer	0.000551	0.000741	CcSEcCtD
Ramipril—Tachycardia—Docetaxel—skin cancer	0.000549	0.000739	CcSEcCtD
Ramipril—Skin disorder—Docetaxel—skin cancer	0.000546	0.000735	CcSEcCtD
Ramipril—Vomiting—Temozolomide—skin cancer	0.000538	0.000724	CcSEcCtD
Ramipril—Anorexia—Docetaxel—skin cancer	0.000536	0.000722	CcSEcCtD
Ramipril—Rash—Temozolomide—skin cancer	0.000533	0.000718	CcSEcCtD
Ramipril—Diarrhoea—Fluorouracil—skin cancer	0.000533	0.000718	CcSEcCtD
Ramipril—Dermatitis—Temozolomide—skin cancer	0.000533	0.000717	CcSEcCtD
Ramipril—Headache—Temozolomide—skin cancer	0.00053	0.000713	CcSEcCtD
Ramipril—Hypotension—Docetaxel—skin cancer	0.000525	0.000707	CcSEcCtD
Ramipril—Dizziness—Fluorouracil—skin cancer	0.000515	0.000694	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000512	0.00069	CcSEcCtD
Ramipril—Insomnia—Docetaxel—skin cancer	0.000509	0.000685	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—skin cancer	0.000505	0.00068	CcSEcCtD
Ramipril—Nausea—Temozolomide—skin cancer	0.000502	0.000676	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—skin cancer	0.000501	0.000675	CcSEcCtD
Ramipril—Somnolence—Docetaxel—skin cancer	0.0005	0.000673	CcSEcCtD
Ramipril—Vomiting—Fluorouracil—skin cancer	0.000495	0.000667	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—skin cancer	0.000495	0.000666	CcSEcCtD
Ramipril—Rash—Fluorouracil—skin cancer	0.000491	0.000661	CcSEcCtD
Ramipril—Dermatitis—Fluorouracil—skin cancer	0.000491	0.000661	CcSEcCtD
Ramipril—Decreased appetite—Docetaxel—skin cancer	0.000489	0.000658	CcSEcCtD
Ramipril—Headache—Fluorouracil—skin cancer	0.000488	0.000657	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—skin cancer	0.000485	0.000653	CcSEcCtD
Ramipril—Fatigue—Docetaxel—skin cancer	0.000485	0.000653	CcSEcCtD
Ramipril—Constipation—Docetaxel—skin cancer	0.000481	0.000647	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—skin cancer	0.000463	0.000624	CcSEcCtD
Ramipril—Nausea—Fluorouracil—skin cancer	0.000463	0.000623	CcSEcCtD
Ramipril—Gastrointestinal pain—Docetaxel—skin cancer	0.00046	0.000619	CcSEcCtD
Ramipril—Body temperature increased—Docetaxel—skin cancer	0.000445	0.000598	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—skin cancer	0.000445	0.000598	CcSEcCtD
Ramipril—Hypersensitivity—Docetaxel—skin cancer	0.000414	0.000558	CcSEcCtD
Ramipril—Asthenia—Docetaxel—skin cancer	0.000403	0.000543	CcSEcCtD
Ramipril—Pruritus—Docetaxel—skin cancer	0.000398	0.000536	CcSEcCtD
Ramipril—Diarrhoea—Docetaxel—skin cancer	0.000385	0.000518	CcSEcCtD
Ramipril—Dizziness—Docetaxel—skin cancer	0.000372	0.000501	CcSEcCtD
Ramipril—Vomiting—Docetaxel—skin cancer	0.000358	0.000481	CcSEcCtD
Ramipril—Rash—Docetaxel—skin cancer	0.000355	0.000477	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—skin cancer	0.000354	0.000477	CcSEcCtD
Ramipril—Headache—Docetaxel—skin cancer	0.000352	0.000474	CcSEcCtD
Ramipril—Nausea—Docetaxel—skin cancer	0.000334	0.00045	CcSEcCtD
